Skip to search formSkip to main contentSkip to account menu

Ticlopidine Hydrochloride

Known as: ticlopidine hcl, Ticlopidine Hydrochloride [Chemical/Ingredient], 5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium Chloride 
The hydrochloride salt form of ticlopidine, a thienopyridine derivative with anticoagulant property. Ticlopidine hydrochloride irreversibly inhibits… 
National Institutes of Health

Related topics

Related topics

13 relations
Blood Coagulation DisordersDrug AllergyHemorrhageIntracranial Embolism and Thrombosis

Narrower (3)

PanaldineTiclidTiclodone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Population-based drug-induced agranulocytosis.
BACKGROUND Since the publication of a major international case-control study on the risk of agranulocytosis associated with the… 
Highly Cited
2005
Highly Cited
2005
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
BACKGROUND Combinations of aspirin with thienopyridine derivatives (clopidogrel bisulfate or ticlopidine hydrochloride) and/or… 
Highly Cited
2002
Highly Cited
2002
Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis.
BACKGROUND Cilostazol is a newly developed antiplatelet drug that has been widely applied for clinical use. Its antiplatelet… 
Review
1999
Review
1999
Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention.
BACKGROUND One of the most unusual causes of thrombotic thrombocytopenic purpura (TTP), a life-threatening disease, is… 
Highly Cited
1999
Highly Cited
1999
Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.
CONTEXT Thrombotic thrombocytopenic purpura (TTP) is a rare and often fatal disorder characterized by thrombocytopenia… 
1999
1999
Adverse cutaneous reactions to ticlopidine in patients with coronary stents.
Review
1996
Review
1996
LINEAR SCLERODERMA IN CHILDREN
Background. Linear scleroderma is a cutaneous disease of unknown etiology. It most often affects children, who develop band‐like… 
Review
1992
Review
1992
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events.
BACKGROUND Recommendations are broadening for the prophylaxis of atherosclerotic disorders, but aspirin is the only widely used… 
1990
1990
Effect of Food and Antacid on Absorption of Orally Administered Ticlopidine Hydrochloride
Ticlopidine is a potent inhibitor of platelet aggregation. Absorption of ticlopidine after oral dosing is rapid and complete… 
Highly Cited
1988
Highly Cited
1988
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Design, organization, and baseline results.
The Canadian American Ticlopidine Study is a randomized, placebo-controlled, double-blind, multicenter study to assess the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)